Ingrid Rechtin advises life sciences, technology, and other companies on complex transactions, with a practice spanning mergers and acquisitions, joint ventures, strategic investments, and other partnering arrangements.

With more than 20 years of experience, Ingrid represents public and private companies through transformative transactions and other critical stages of their development. She draws on broad experience across transaction structures and industries to help clients achieve their strategic objectives, structure durable commercial relationships, and navigate legal and regulatory complexity.

Ingrid has a substantial life sciences practice, advising pharmaceutical and biotechnology companies on acquisitions and divestitures, option-to-acquire transactions, strategic investments, and other transactions that bring together corporate, commercial, intellectual property, licensing, and regulatory considerations. As a co-chair of Covington’s Technology Industry Group, she also advises on transactions involving AI, digital infrastructure, data centers, and other emerging technologies.

Ingrid regularly leads cross-border transactions involving businesses and operations across North America, Europe, Asia, and other key markets. She also has significant experience advising corporate venture capital and other strategic investors, particularly where an investment is coupled with commercial, governance, licensing, or acquisition rights. Her practice also includes global internal restructurings, complex commercial transactions, and acquisitions and divestitures of intellectual property assets.